Nexplanon 68 MG implants

Ended Awarded Last action

Contract number
SPE2DR26FCSC4
Awardee
Awarding agency
Obligated
$25,144

Award facts

Contract value 100% obligated
$25,144.20 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for Nexplanon 68 mg implants with a ceiling value of $25,144.20 and an ultimate completion date of March 23, 2026.

DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract established to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. Place of performance is Park Ridge, IL. Pricing is firm fixed price.

Quick answers

Who was awarded contract SPE2DR26FCSC4?

SPE2DR26FCSC4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 2, 2026.

How much is contract SPE2DR26FCSC4 worth?

The government has obligated $25,144 on SPE2DR26FCSC4.

Is contract SPE2DR26FCSC4 an order under another contract?

Yes. SPE2DR26FCSC4 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.

Was contract SPE2DR26FCSC4 competed?

The extent of competition for SPE2DR26FCSC4 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award